ArticleDie Ophthalmologie2026
[Photophobia in a young patient with atonic pupils and iris transillumination].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 22-year-old female patient was referred for glaucoma evaluation due to an unclear bilateral ocular condition. For 6 months she had experienced glare sensitivity and dilated pupils without visual impairment. Initially, bilateral anterior uveitis with elevated intraocular pressure (IOP) had been diagnosed and treated locally with topical steroids and latanoprost. Clinical examination revealed bilateral diffuse iris transillumination defects with irregular, nonreactive mydriasis as well as heavily pigmented anterior chamber angles. Extended medical history revealed pneumonia treated with systemic moxifloxacin 2 weeks prior to symptom onset. Based on this correlation, the diagnosis of bilateral acute iris transillumination syndrome (BAIT) was established, which is a rare and likely underdiagnosed syndrome that is frequently mistaken for uveitis or pigment dispersion syndrome. Although the pathogenesis has not yet been fully clarified, associations with moxifloxacin therapy and respiratory tract infections have been described. Middle-aged women are predominantly affected. Clinically, the acute phase is characterized by conjunctival hyperemia combined with loss of the iris pigment epithelium, resulting in acute pigment dispersion into the anterior chamber. Subsequently, irreversible diffuse iris transillumination defects and enlarged atonic pupils develop. Pigment deposition within the anterior chamber angle can lead to ocular hypertension and rarely a secondary glaucoma. Careful history taking, regular IOP monitoring and symptomatic treatment of photophobia are essential. Awareness of this syndrome prevents unnecessary, time-consuming and costly uveitis work-up.
Indexed as
Identifiers
42154262What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.